Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Nikolitsa Nomikou
Room 304
South Wing, 9th Floor, Royal Free Hospital
Pond Street
Prof Nikolitsa Nomikou profile picture
  • Professor of Advanced Therapeutics
  • Department of Surgical Biotechnology
  • Div of Surgery & Interventional Sci
  • Faculty of Medical Sciences

Professor Nomikou completed her doctorate in Biomedical Sciences at Ulster University in 2008. She was appointed as Lecturer in Targeted Therapeutics at UCL in September 2013, she was then promoted to Associate Professor in October 2019 and to Professor of Advanced Therapeutics in October 2021.

Research Groups
Research Themes
Research Summary

Professor Nomikou’s current research focuses on the development of translational drug delivery approaches based on formulations/carriers that are responsive to different forms of energy (electromagnetic fields, ultrasound), as well as responsive to the cancerous microenvironment. Her recently published and current funded research has demonstrated the potential of site-specific and minimally-invasive treatments based on low-intensity ultrasound and light, named as sonodynamic and photodynamic/photothermal therapy, respectively.  The potential of these therapeutic approaches to efficiently manage aggressive and advanced-stage cancers has been strongly augmented by novel therapeutic formulations that respond to either externally-applied or tumour-specific stimuli.  Professor Nomikou’s team aims to optimize these therapeutic modalities using nanotechnology for maximizing their potential in the clinic. Her research has been awarded funding from the UK Research Councils (EPSRC, MRC), the Royal Society, as well as UK-based cancer charities (e.g. Bowel& Cancer Research). Her research has also been supported with private donations. She is the Group Lead of Responsive Oncotherapeutics at UCL.

PhD opportunities on one of the following topics:

a. Stimulus-responsive therapeutic formulations for cancer treatment and drug delivery

b. Development and characterization of therapeutic formulations for cancer sonodynamic therapy

c. Exploitation of the tumour microenvironment in therapy

d. Combined intraoperative NIR imaging and treatment for cancer

Teaching Summary

Programme Lead - iBSc in Surgical Sciences

Year 3 Lead - BSc in Applied Medical Sciences

Module coordinator SURG0057 - Surgical Oncology   (iBSc in Surgical Sciences)

Module coordinator SURGGS03 - Surgical Oncology (MSc in Surgical & Interventional Science)

Some IRIS profile information is sourced from HR data as explained in our FAQ. Please report any queries concerning HR data shown on this page to hr-services@ucl.ac.uk.
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by